IRS 19 - instructions for use, reviews, analogs and forms of release (nasal spray) for the treatment and prophylaxis of sinusitis, pharyngitis, laryngitis in adults, children and pregnancy
In this article, you can read the instructions for using the drug IRS 19. Presented are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors specialists on the use of IRS 19 in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of IRS 19 in the presence of existing structural analogues. Use for the treatment and prevention of sinusitis, pharyngitis, laryngitis in adults, children, as well as during pregnancy and lactation.
IRS 19 - immunostimulating drug based on bacterial lysates. IRS 19 increases specific and nonspecific immunity.
When spraying IRS 19, a fine aerosol is formed which covers the mucous membrane of the nose, which leads to a rapid development of the local immune response. Specific protection is due to locally formed antibodies of the class of secretory immunoglobulins type A (IgA), which prevent fixation and reproduction of pathogens of infection on the mucosa. Nonspecific immunoprotection is manifested in an increase in the phagocytic activity of macrophages, an increase in the content of lysozyme.
Composition
Lysates of bacteria (staphylococci, streptococci, enterococci, Klebsiella and others) + auxiliary substances.
Pharmacokinetics
The drug mainly acts in the upper respiratory tract; currently there are no data on systemic absorption of the drug.
Indications
Adults and children older than 3 months:
- prevention of chronic diseases of the upper respiratory tract and bronchi;
- treatment of acute and chronic diseases of the upper respiratory tract and bronchi, such as rhinitis, sinusitis, laryngitis, pharyngitis, tonsillitis, tracheitis, bronchitis and others;
- restoration of local immunity after a previous influenza or other viral infections;
- preparation for routine surgical intervention on the ENT organs and postoperative period.
Forms of release
Spray nasal.
Instructions for use and how to use them
The drug is applied intranasally (in the nose) by aerosol administration of 1 dose (1 dose = 1 short pressing of the atomizer).
In order to prevent adults and children from 3 months, 1 dose of the drug is injected into each nostril 2 times a day for 2 weeks (it is recommended to start the treatment 2-3 weeks before the expected increase in the incidence).
For the treatment of acute and chronic diseases of the upper respiratory tract and bronchial tubes, children from 3 months to 3 years of age are prescribed 1 dose of drug per nostril 2 times a day after prior clearance from mucous discharge to disappearance of symptoms of infection; children older than 3 years and adults - 1 dose of drug in each nostril from 2 to 5 times a day until the symptoms of infection disappear.
To restore local immunity after a previous flu and other respiratory viral infections, children and adults are prescribed 1 dose of drug per nostril 2 times a day for 2 weeks.
In preparation for routine surgery and in the postoperative period, adults and children are prescribed 1 dose of drug per nostril 2 times a day for 2 weeks (starting treatment is recommended 1 week before the planned surgery).
Terms of use
For the correct functioning of the aerosol canister, put the nozzle on the cylinder, center it and gently, without effort, press it. After that, the device is ready for use.
When injecting the drug, the vial should be in a strictly upright position, the patient should not tilt the head.
If you tilt the cylinder during the injection, the propellant will leak out in a few seconds and the device will become unusable.
With regular use of the drug is not recommended to remove the nozzle from the bottle.
If the drug is left for a long time without use, a drop of liquid may evaporate and the formed crystals will clog the outlet of the nozzle. This occurs most often when the nozzle is removed and put into the package top end down next to the balloon, without previously washing and drying it.If there is a blockage of the nozzle, several strokes should be done in a row, so that the liquid can pass under the effect of excessive pressure; If there is no effect, lower the nozzle for a few minutes in warm water.
Side effect
- erythema-like and eczematic reactions;
- thrombocytopenic purpura;
- erythema nodosum;
- hives;
- angioedema;
- asthma attacks and cough;
- rhinopharyngitis;
- sinusitis;
- laryngitis;
- bronchitis;
- nausea, vomiting;
- abdominal pain;
- diarrhea;
- increase in body temperature (> 39 ° C) for no apparent reason.
Contraindications
- autoimmune diseases;
- hypersensitivity to the components of the drug.
Application in pregnancy and lactation
There is insufficient data on the potential for teratogenic or toxic effects on the fetus during pregnancy. Therefore, the use of IRS 19 during pregnancy is not recommended.
special instructions
At the beginning of the treatment, reactions such as sneezing and increased discharge from the nose may occur. As a rule, they are of a short-term nature. If these reactions take a severe course, reduce the frequency of administration of the drug or cancel it.
At the beginning of treatment in rare cases, an increase in body temperature ≥ 39 ° C is possible. In this case, the drug should be canceled. However, it is necessary to distinguish this state from an increase in body temperature accompanied by malaise, which may be associated with the development of diseases of the ENT organs.
In the case of the emergence of clinical symptoms of bacterial infection should consider the appropriateness of systemic antibiotics.
When prescribing an IRS, 19 patients with bronchial asthma may experience an increase in seizures. In this case, it is recommended to stop treatment and not take this class of drugs in the future.
Impact on the ability to drive vehicles and manage mechanisms
IRS 19 does not affect the psychomotor functions associated with the driving of vehicles or the management of machines and mechanisms.
Drug Interactions
Drug interaction of the drug IRS 19 is unknown.
Perhaps the appointment of antibiotics against the backdrop of continued use of IRS 19.
Analogues of medicinal product IRS 19
The IRS 19 has no structural analogs for the active substance. The drug is unique in the composition of its constituent components.
Similar medicines:
Other medicines:
- Tavegil - instructions for use, reviews, analogs and forms of release (tablets 1 mg, syrup, injections in ampoules for injection) drugs for the treatment of allergies in adults, children and pregnancy. Interaction with alcohol
- Calcemin - instructions for use, reviews, analogs and forms of release (tablets, Advance with magnesium) drug for the treatment of hypovitaminosis and osteoporosis in adults, children and pregnancy. Composition of vitamins and course duration
- Sodium thiosulfate - instructions for use, analogs, testimonials and release forms (injections in injectable vials) of the antidote drug for the treatment of allergies and poisonings by arsenic, lead in adults, children and during pregnancy